GoHealth Inc. (GOCO) Misses Q1 EPS by 3c, Offers Guidance

GoHealth Inc. (NASDAQ: GOCO) reported Q1 EPS of ($0.12), $0.03 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $270.6 million versus the consensus estimate of $162.65 million.

GUIDANCE:

GoHealth Inc. sees FY2022 revenue of $900-1100 million, versus the consensus of $993.5 million.

• Full-year 2022 net revenue of $900 - $1,100 million, representing year-over-year growth of (15)% - 4%
• Full-year 2022 commission revenue of $700 - $900 million, representing year-over-year growth of (21)% - 2%, fueled by the Company's continued investment in its Medicare business
• Full-year 2022 Adjusted EBITDA of $110 - $150 million, representing year-over-year growth of 224% - 343%
• Full-year 2022 cash flow from operations of ($50) - ($10) million, representing year-over-year improvement of 83% to 97%

For earnings history and earnings-related data on GoHealth Inc. (GOCO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c